Folgen
Dr. Nils A Kulak
Dr. Nils A Kulak
PreOmics GmbH
Bestätigte E-Mail-Adresse bei preomics.com - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells
NA Kulak, G Pichler, I Paron, N Nagaraj, M Mann
Nature methods 11 (3), 319-324, 2014
12982014
Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans
LM Holdt, A Stahringer, K Sass, G Pichler, NA Kulak, W Wilfert, ...
Nature communications 7 (1), 1-14, 2016
7482016
Plasma proteome profiling to assess human health and disease
PE Geyer, NA Kulak, G Pichler, LM Holdt, D Teupser, M Mann
Cell systems 2 (3), 185-195, 2016
4672016
System-wide perturbation analysis with nearly complete coverage of the yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap
N Nagaraj, NA Kulak, J Cox, N Neuhauser, K Mayr, O Hoerning, O Vorm, ...
Molecular & Cellular Proteomics 11 (3), 2012
4362012
The coming age of complete, accurate, and ubiquitous proteomes
M Mann, NA Kulak, N Nagaraj, J Cox
Molecular cell 49 (4), 583-590, 2013
3692013
The impact II, a very high-resolution quadrupole time-of-flight instrument (QTOF) for deep shotgun proteomics
S Beck, A Michalski, O Raether, M Lubeck, S Kaspar, N Goedecke, ...
Molecular & Cellular Proteomics 14 (7), 2014-2029, 2015
1712015
Ultra-deep and quantitative saliva proteome reveals dynamics of the oral microbiome
N Grassl, NA Kulak, G Pichler, PE Geyer, J Jung, S Schubert, P Sinitcyn, ...
Genome medicine 8 (1), 1-13, 2016
1672016
Loss-less nano-fractionator for high sensitivity, high coverage proteomics
NA Kulak, PE Geyer, M Mann
Molecular & Cellular Proteomics 16 (4), 694-705, 2017
1432017
A double-barrel liquid chromatography-tandem mass spectrometry (LC-MS/MS) system to quantify 96 interactomes per day
F Hosp, RA Scheltema, HC Eberl, NA Kulak, EC Keilhauer, K Mayr, ...
Molecular & Cellular Proteomics 14 (7), 2030-2041, 2015
332015
Proteomics analysis of monocyte-derived hepatocyte-like cells identifies integrin beta 3 as a specific biomarker for drug-induced liver injury by diclofenac
D Dragoi, A Benesic, G Pichler, NA Kulak, HS Bartsch, AL Gerbes
Frontiers in pharmacology 9, 699, 2018
142018
Scaling of cellular proteome with ploidy
G Yahya, P Menges, DA Ngandiri, D Schulz, A Wallek, N Kulak, M Mann, ...
bioRxiv, 2021
42021
Novel technologies enabling streamlined complete proteome analysis
NA Kulak
lmu, 2014
12014
Means and methods for lysing biological cells
NA Kulak, V Ribeiro-celinski
US Patent App. 17/254,841, 2021
2021
Hydrophobicity based flow prevention in sample preparation
G Pichler, NA Kulak
US Patent App. 16/345,642, 2019
2019
Means and methods for a sample preparation, especially for mass spectrometry
NA Kulak, G Pichler, M Mann
US Patent App. 15/747,431, 2018
2018
A potential novel biomarker for Drug-induced Liver Injury by Diclofenac identified by the combination of MH cells and proteomics
A Benesic, D Dragoi, G Pichler, N Kulak, H Bartsch, A Gerbes
Zeitschrift für Gastroenterologie 56 (08), KV 147, 2018
2018
Peptide purification using mixed-phase solid phase extraction material
NA Kulak, G Pichler, M Mann
US Patent App. 15/741,804, 2018
2018
Proteomanalyse von hepatozyten-ähnlichen Zellen monozytären Ursprungs identifiziert ITGB3 als Biomarker für medikamentös-toxische Leberschäden durch Diclofenac
D Dragoi, A Benesic, G Pichler, NA Kulak, HS Bartsch, AL Gerbes
Zeitschrift für Gastroenterologie 56 (05), PP4, 2018
2018
Reaction Vessel for Sample Preparation
NA Kulak, M Mann, SB Azimifar, N Nagaraj
US Patent App. 15/703,353, 2018
2018
Means and methods for minimizing swept and dead volumes in chromatographic applications
N Kulak, M Mann
US Patent App. 15/549,656, 2018
2018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20